REF2014: demonstrating UCL’s research impact

The Research Excellence Framework (REF) assesses research in all higher education institutions in all disciplines. Submissions are made to 36 subject sub-panels co-ordinated under four main panels: A, B, C and D. Assessing 'impact' is a key component of the REF assessment, weighted 20% of the final score awarded. As part of its submission, UCL provided hundreds of case studies to demonstrate the impact of the 'reach and significance' of its research in the wider world beyond academia. These case studies have now been made available online on a new website: www.ucl.ac.uk/impact Examples from across UCL highlight how the university's research activity addresses the challenges facing the world, bringing benefits in health, culture, policy, business and beyond. A small selection of case studies from each main panel are highlighted below. Main Panel A. Improved treatment for Tuberculosis patients worldwide Lead academics: Professor Andrew Nunn, Dr Amina Jindani, Professor Donald Enarson (UCL Institute of Clinical Trials & Methodology and UCL Population Health Sciences) UCL research led to changes in World Health Organization recommendations on the treatment of tuberculosis. These have been adopted by almost all countries, leading to improved treatment for nearly 8 million patients, and reducing the number suffering relapse.